[RNA splicing dysregulation in hematological malignancies].

Yoshida, Mina; Yamauchi, Hirofumi; Sakumoto, Marimu; Yoshimi, Akihide

Yoshida, Mina; Yamauchi, Hirofumi; Sakumoto, Marimu; Yoshimi, Akihide.

Yoshida M; Department of Hematology, Saitama Medical Center, Saitama Medical University.
Yamauchi H; Division of Cancer RNA Research, National Cancer Center Research Institute.
Sakumoto M; Division of Cancer RNA Research, National Cancer Center Research Institute.
Yoshimi A; Division of Cancer RNA Research, National Cancer Center Research Institute.

Rinsho Ketsueki ; 64(7): 646-653, 2023.

Article en Ja | MEDLINE | ID: mdl-37544725

Asunto(s)

Neoplasias Hematológicas; Leucemia Mieloide Aguda; Humanos; Empalme del ARN/genética; Factores de Empalme de ARN/genética; Neoplasias Hematológicas/genética; Empalmosomas/genética; Empalmosomas/metabolismo; Mutación; ARN Mensajero/metabolismo

Palabras clave

Epigenetics; Leukemia; SF3b Inhibitor; Splicing

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Neoplasias Hematológicas Límite: Humans Idioma: Ja Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google